Cargando…
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
The EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy. Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in these patients.
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575532/ https://www.ncbi.nlm.nih.gov/pubmed/34749396 http://dx.doi.org/10.1182/bloodadvances.2021005616 |
| _version_ | 1784595691860918272 |
|---|---|
| author | Busca, Alessandro Salmanton-García, Jon Corradini, Paolo Marchesi, Francesco Cabirta, Alba Di Blasi, Roberta Dulery, Remy Lamure, Sylvain Farina, Francesca Weinbergerová, Barbora Batinić, Josip Nordlander, Anna López-García, Alberto Drgoňa, Ľuboš Espigado-Tocino, Ildefonso Falces-Romero, Iker García-Sanz, Ramón García-Vidal, Carolina Guidetti, Anna Khanna, Nina Kulasekararaj, Austin Maertens, Johan Hoenigl, Martin Klimko, Nikolai Koehler, Philipp Pagliuca, Antonio Passamonti, Francesco Cornely, Oliver A. Pagano, Livio |
| author_facet | Busca, Alessandro Salmanton-García, Jon Corradini, Paolo Marchesi, Francesco Cabirta, Alba Di Blasi, Roberta Dulery, Remy Lamure, Sylvain Farina, Francesca Weinbergerová, Barbora Batinić, Josip Nordlander, Anna López-García, Alberto Drgoňa, Ľuboš Espigado-Tocino, Ildefonso Falces-Romero, Iker García-Sanz, Ramón García-Vidal, Carolina Guidetti, Anna Khanna, Nina Kulasekararaj, Austin Maertens, Johan Hoenigl, Martin Klimko, Nikolai Koehler, Philipp Pagliuca, Antonio Passamonti, Francesco Cornely, Oliver A. Pagano, Livio |
| author_sort | Busca, Alessandro |
| collection | PubMed |
| description | The EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy. Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in these patients. |
| format | Online Article Text |
| id | pubmed-8575532 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85755322021-11-09 COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP Busca, Alessandro Salmanton-García, Jon Corradini, Paolo Marchesi, Francesco Cabirta, Alba Di Blasi, Roberta Dulery, Remy Lamure, Sylvain Farina, Francesca Weinbergerová, Barbora Batinić, Josip Nordlander, Anna López-García, Alberto Drgoňa, Ľuboš Espigado-Tocino, Ildefonso Falces-Romero, Iker García-Sanz, Ramón García-Vidal, Carolina Guidetti, Anna Khanna, Nina Kulasekararaj, Austin Maertens, Johan Hoenigl, Martin Klimko, Nikolai Koehler, Philipp Pagliuca, Antonio Passamonti, Francesco Cornely, Oliver A. Pagano, Livio Blood Adv Stimulus Report The EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy. Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in these patients. American Society of Hematology 2022-04-11 /pmc/articles/PMC8575532/ /pubmed/34749396 http://dx.doi.org/10.1182/bloodadvances.2021005616 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://www.ncbi.nlm.nih.gov/pmc/pmcdoc/tagging-guidelines/article/tags.html#el-licenseThis article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
| spellingShingle | Stimulus Report Busca, Alessandro Salmanton-García, Jon Corradini, Paolo Marchesi, Francesco Cabirta, Alba Di Blasi, Roberta Dulery, Remy Lamure, Sylvain Farina, Francesca Weinbergerová, Barbora Batinić, Josip Nordlander, Anna López-García, Alberto Drgoňa, Ľuboš Espigado-Tocino, Ildefonso Falces-Romero, Iker García-Sanz, Ramón García-Vidal, Carolina Guidetti, Anna Khanna, Nina Kulasekararaj, Austin Maertens, Johan Hoenigl, Martin Klimko, Nikolai Koehler, Philipp Pagliuca, Antonio Passamonti, Francesco Cornely, Oliver A. Pagano, Livio COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP |
| title | COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP |
| title_full | COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP |
| title_fullStr | COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP |
| title_full_unstemmed | COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP |
| title_short | COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP |
| title_sort | covid-19 and car t cells: a report on current challenges and future directions from the epicovideha survey by eha-idwp |
| topic | Stimulus Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575532/ https://www.ncbi.nlm.nih.gov/pubmed/34749396 http://dx.doi.org/10.1182/bloodadvances.2021005616 |
| work_keys_str_mv | AT buscaalessandro covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT salmantongarciajon covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT corradinipaolo covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT marchesifrancesco covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT cabirtaalba covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT diblasiroberta covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT duleryremy covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT lamuresylvain covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT farinafrancesca covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT weinbergerovabarbora covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT batinicjosip covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT nordlanderanna covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT lopezgarciaalberto covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT drgonalubos covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT espigadotocinoildefonso covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT falcesromeroiker covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT garciasanzramon covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT garciavidalcarolina covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT guidettianna covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT khannanina covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT kulasekararajaustin covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT maertensjohan covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT hoeniglmartin covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT klimkonikolai covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT koehlerphilipp covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT pagliucaantonio covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT passamontifrancesco covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT cornelyolivera covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp AT paganolivio covid19andcartcellsareportoncurrentchallengesandfuturedirectionsfromtheepicovidehasurveybyehaidwp |